Receptor binding domain proteins of SARS‐CoV‐2 variants produced in <i>Nicotiana benthamiana</i> elicit neutralizing antibodies against variants of concern-Reference-Cited by-同舟云学术

Receptor binding domain proteins of SARS‐CoV‐2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern

Published:2022-06 Issue:9 Volume:94 Page:4265-4276
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Khorattanakulchai Narach¹²,Manopwisedjaroen Suwimon³,Rattanapisit Kaewta⁴,Panapitakkul Chalisa¹²,Kemthong Taratorn⁵,Suttisan Nutchanat⁵,Srisutthisamphan Kanjana⁶,Malaivijitnond Suchinda⁵,Thitithanyanont Arunee³,Jongkaewwattana Anan⁶,Shanmugaraj Balamurugan⁴^ORCID,Phoolcharoen Waranyoo¹²^ORCID

Affiliation:

1. Center of Excellence in Plant‐produced Pharmaceuticals Chulalongkorn University Bangkok Thailand

2. Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences Chulalongkorn University Bangkok Thailand

3. Department of Microbiology, Faculty of Science Mahidol University Bangkok Thailand

4. Baiya Phytopharm Co., Ltd Bangkok Thailand

5. National Primate Research Center of Thailand Chulalongkorn University Saraburi Thailand

6. Virology and Cell Technology Laboratory, National Center for Genetic Engineering and Biotechnology (BIOTEC) National Science and Technology Development Agency Pathumthani Thailand

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27881

Reference49 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

2. World Health Organization. WHO Director‐General's opening remarks at the media briefing on COVID‐19 ‐ 11 March 2020. Accessed May 23 2022.https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

3. World Health Organization. WHO coronavirus (COVID‐19) dashboard.2020. Accessed May 23 2022.https://covid19.who.int/

4. World Health Organization. DRAFT landscape of COVID‐19 candidate vaccines.2021. Accessed May 23 2022.https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

5. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diverse approaches to express recombinant spike protein: A comprehensive review;Protein Expression and Purification;2024-11

2. Quality control in SARS-CoV-2 RBD-Fc vaccine production using LC–MS to confirm strain selection and detect contaminations from other strains;Scientific Reports;2024-04-26

3. A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection;Nature Communications;2024-02-02

4. Performance of plant-produced RBDs as SARS-CoV-2 diagnostic reagents: a tale of two plant platforms;Frontiers in Plant Science;2024-01-04

5. Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers;Scientific Reports;2023-09-20